W6134
Product Specifications
UNSPSC Description
W6134 is highly potent and selective RORγ covalent inhibitor with IC50 of 0.21 μM. W6134 exhibits superior activity ini nhibiting the proliferation and colony formation and inducing apoptosis. W6134 can be used for the research of cancer[1].
Target Antigen
ROR
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease;Vitamin D Related/Nuclear Receptor
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/w6134.html
Solubility
DMSO : 83.33 mg/mL (ultrasonic)
Smiles
O=C(NC1=CC=C(C2=C(C=CC=C2)NC(C=C)=O)C(Cl)=C1)CC3=CC=C(C=C3)S(=O)(CC)=O
Molecular Weight
482.98
References & Citations
[1]Fang W, et al. Discovery of the First-in-Class RORγ Covalent Inhibitors for Treatment of Castration-Resistant Prostate Cancer. J Med Chem. 2024 Jan 16.
Shipping Conditions
Blue Ice
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-163192/W6134-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-163192/W6134-SDS-MedChemExpress.pdf
Clinical Information
No Development Reported
CAS Number
2983540-55-0
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![Rabbit Monoclonal OX40 Ligand/TNFSF4 Antibody (R4930 (Oxelumab)) [DyLight 594]](https://cdn.genprice.uk/genprice/genprice3.png)
NBP2-52687DL594 0.1 mL
Rabbit Monoclonal OX40 Ligand/TNFSF4 Antibody (R4930 (Oxelumab)) [DyLight 594]
Ask
View Details 
67087121 3 x 1.0μg DNA
RPS4P17 CRISPRa sgRNA lentivector (set of three targets)(Human)
Ask
View Details 
